Strategies for High-Efficiency Mutation Using the CRISPR/Cas System.

Feng, Shuying; Wang, Zilong; Li, Aifang; Xie, Xin; Liu, Junjie; Li, Shuxuan; Li, Yalan; Wang, Baiyan; Hu, Lina; Yang, Lianhe; Guo, Tao

Feng, Shuying; Wang, Zilong; Li, Aifang; Xie, Xin; Liu, Junjie; Li, Shuxuan; Li, Yalan; Wang, Baiyan; Hu, Lina; Yang, Lianhe; Guo, Tao.

Afiliación

Feng S; Medical College, Henan University of Chinese Medicine, Zhengzhou, China.
Wang Z; Medical College, Henan University of Chinese Medicine, Zhengzhou, China.
Li A; Medical College, Henan University of Chinese Medicine, Zhengzhou, China.
Xie X; Medical College, Henan University of Chinese Medicine, Zhengzhou, China.
Liu J; Medical College, Henan University of Chinese Medicine, Zhengzhou, China.
Li S; Medical College, Henan University of Chinese Medicine, Zhengzhou, China.
Li Y; Medical College, Henan University of Chinese Medicine, Zhengzhou, China.
Wang B; Medical College, Henan University of Chinese Medicine, Zhengzhou, China.
Hu L; Medical College, Henan University of Chinese Medicine, Zhengzhou, China.
Yang L; Medical College, Henan University of Chinese Medicine, Zhengzhou, China.
Guo T; Department of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China.

Front Cell Dev Biol ; 9: 803252, 2021.

Article en En | MEDLINE | ID: mdl-35198566

Palabras clave

CRISPR/Cas system; highly efficient; mutant; off-target effect; optimized strategies

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Front Cell Dev Biol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google